Cartesian Therapeutics Inc (RNAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 87,227 | 103,418 | 76,911 | 79,603 | 112,027 |
| Receivables | 35,511 | 4,376 | 8,851 | 6,773 | 6,440 |
| TOTAL | $124,782 | $111,109 | $90,729 | $89,869 | $122,725 |
| Non-Current Assets | |||||
| PPE Net | 6,672 | 2,402 | 2,113 | 2,421 | 2,593 |
| Investments And Advances | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 |
| Intangibles | 48,163 | 48,163 | 48,163 | 0 | 0 |
| Other Non-Current Assets | 166,121 | 161,533 | 162,045 | 11,744 | 12,188 |
| TOTAL | $222,956 | $214,098 | $214,321 | $16,165 | $16,781 |
| Total Assets | $347,738 | $325,207 | $305,050 | $106,034 | $139,506 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 0 | 10,235 |
| Accounts payable and accrued liabilities | 2,862 | 2,517 | 3,150 | 375 | 267 |
| Accrued Expenses | 10,954 | 9,516 | 15,572 | 13,637 | 12,902 |
| Other current liabilities | 9,776 | 21,980 | 45,010 | N/A | N/A |
| TOTAL | $26,115 | $36,654 | $68,209 | $19,939 | $29,367 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 0 | 13,787 |
| Deferred Revenues | N/A | 412 | 2,311 | 4,140 | 4,234 |
| Other Non-Current Liabilities | 407,228 | 389,500 | 357,080 | 21,785 | 26,041 |
| TOTAL | $423,081 | $405,353 | $376,471 | $25,766 | $44,691 |
| Total Liabilities | $449,196 | $442,007 | $444,680 | $45,705 | $74,058 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 21,382 | 17,796 | 5,393 | 5,168 | 5,109 |
| Common Shares | 2 | 1 | 1 | 15 | 15 |
| Retained earnings | -657,635 | -671,471 | -614,647 | -436,989 | -427,987 |
| Other shareholders' equity | -4,591 | -4,605 | -4,600 | -4,616 | -4,596 |
| TOTAL | $-101,458 | $-116,800 | $-139,630 | $60,329 | $65,448 |
| Total Liabilities And Equity | $347,738 | $325,207 | $305,050 | $106,034 | $139,506 |